Miravalle A - Search Results

1

Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy.

Miravalle A, Jensen R, Kinkel RP. Miravalle A, et al. Arch Neurol. 2011 Feb;68(2):186-91. doi: 10.1001/archneurol.2010.257. Epub 2010 Oct 11. Arch Neurol. 2011. PMID: 20937940

2

Encephalitis complicating smallpox vaccination.

Miravalle A, Roos KL. Miravalle A, et al. Arch Neurol. 2003 Jul;60(7):925-8. doi: 10.1001/archneur.60.7.925. Arch Neurol. 2003. PMID: 12873847 Review.

3

Considerations on discontinuing natalizumab for the treatment of multiple sclerosis.

Berger JR, Centonze D, Comi G, Confavreux C, Cutter G, Giovannoni G, Gold R, Hartung HP, Lublin F, Miravalle A, Montalban X, O'Connor P, Olsson T, Polman CH, Stuve O, Wolinsky JS, Ziemssen T. Berger JR, et al. Among authors: miravalle a. Ann Neurol. 2010 Sep;68(3):409-11. doi: 10.1002/ana.22083. Ann Neurol. 2010. PMID: 20818795 No abstract available.

4

Therapeutic options in multiple sclerosis: five new things.

Miravalle A, Corboy JR. Miravalle A, et al. Neurology. 2010 Nov 2;75(18 Suppl 1):S22-7. doi: 10.1212/WNL.0b013e3181fb3676. Neurology. 2010. PMID: 21041767 Review. No abstract available.

5

Recent insights into the mechanism of action of glatiramer acetate.

Kala M, Miravalle A, Vollmer T. Kala M, et al. Among authors: miravalle a. J Neuroimmunol. 2011 Jun;235(1-2):9-17. doi: 10.1016/j.jneuroim.2011.01.009. Epub 2011 Mar 13. J Neuroimmunol. 2011. PMID: 21402415 Review.

6

Guidelines and best practices for appropriate use of dalfampridine in managed care populations.

Miravalle AA. Miravalle AA. Am J Manag Care. 2011 May;17 Suppl 5 Improving:S154-60. Am J Manag Care. 2011. PMID: 21761954 Review.

7

Emerging therapies for treatment of multiple sclerosis.

Corboy JR, Miravalle AA. Corboy JR, et al. Among authors: miravalle aa. J Inflamm Res. 2010;3:53-9. doi: 10.2147/jir.s6558. Epub 2010 Jul 23. J Inflamm Res. 2010. PMID: 22096357 Free PMC article.

8

Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab.

Kleinschmidt-DeMasters BK, Miravalle A, Schowinsky J, Corboy J, Vollmer T. Kleinschmidt-DeMasters BK, et al. Among authors: miravalle a. J Neuropathol Exp Neurol. 2012 Jul;71(7):604-17. doi: 10.1097/NEN.0b013e31825caf2c. J Neuropathol Exp Neurol. 2012. PMID: 22710964 Review.

9

Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine.

Schreiner TL, Miravalle A. Schreiner TL, et al. Among authors: miravalle a. J Cent Nerv Syst Dis. 2012 Jan 3;4:1-14. doi: 10.4137/JCNSD.S5128. Print 2012. J Cent Nerv Syst Dis. 2012. PMID: 23650463 Free PMC article.

10

Neurologic complications of vaccinations.

Miravalle AA, Schreiner T. Miravalle AA, et al. Handb Clin Neurol. 2014;121:1549-57. doi: 10.1016/B978-0-7020-4088-7.00103-6. Handb Clin Neurol. 2014. PMID: 24365435 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results